FDA Inspection 934359 — Kabco Pharmaceuticals, Inc.

Kabco Pharmaceuticals, Inc. — FEI 2434805

The FDA completed an inspection of Kabco Pharmaceuticals, Inc. on June 30, 2015 in Amityville, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Food/Cosmetics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 30, 2015
Fiscal Year
2015
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Amityville, NY (United States)